ARVO 2018: World’s Largest Show and Tell for Innovations in Eye Research

In addition to funding sight-saving research, we at FFB work hard to tell the scientific world about it. That’s because knowledge sharing and collaboration are critical to accelerating the advancement of promising therapies. Progress in developing treatments and cures isn’t made in a vacuum. The best opportunity for us to showcase FFB-funded research is at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO), which is being held April 29 – May 3 this year ....Continue reading

Omega-3s no better than placebo for treating dry eye

Patients with dry eye may not significantly benefit from supplementation with fish-derived omega-3 fatty acids, according to findings from a year-long randomized controlled trial. The results, reported earlier this month in The New England Journal of Medicine, are the most reliable and generalizable evidence thus far on omega-3 supplementation for dry eye disease, and goes against what previous trials have shown. These new observ....Continue reading

Novel treatment restores corneal clarity in patients with bullous keratopathy

Researchers from Japan treated bullous keratopathy with an injection of cultured human corneal endothelial cells (CECs) supplemented with a rho-associated protein kinase (ROCK) inhibitor. Study design This non-randomized prospective study enrolled 11 patients with corneal edema secondary to Fuchs endothelial dystrophy or pseudophakic bullous keratopathy. The patients had no detectable endothelial cells on specular microscopy, a central corneal thickness greater than 630 μm and frank epithelial....Continue reading

Cataract Surgery

Metabolic changes of the crystalline lens fibers in your eye can lead to opacification and loss of transparency of the lens in the eye over time. This could lead to vision impairment. During cataract surgery, the cloudy natural “cataract” lens in your eye is removed and replaced with a synthetic lens to restore clear vision. Laser cataract surgery Laser cataract surgery was first performed in the USA in 2010. Due to the precision, quick turnaround time, consistency and convenience offered ....Continue reading

Retinal Patch Performs Promisingly in Clinical Trial for Dry AMD Patients

 Regenerative Patch Technologies, a company developing stem-cell-derived treatments for people with retinal diseases, has reported encouraging results for the first five patients with advanced, dry age-related macular degeneration (AMD) participating in a Phase 1/2a clinical trial for its therapy – a patch comprised of a layer of retinal pigment epithelial (RPE) cells on a synthet....Continue reading
Page 1 of 3123

© Copyright Lehigh Valley Center For Sight